Supplemental Materials for Fiorillo et al. Efficacy And Safety Of Apremilast In Pediatric Patients With Moderate-To-Severe Plaque Psoriasis: 16-Week Results From SPROUT, A Randomized Controlled Trial

Name: Supplemental Materials for Fiorillo et al. Efficacy And Safety Of Apremilast In Pediatric Patients With Moderate-To-Severe Plaque Psoriasis: 16-Week Results From SPROUT, A Randomized Controlled Trial
Creator: Loretta Fiorillo
Published: 2023-12-21T13:32:38.271Z
Keywords: Pediatrics, Clinical Trial, Systemic Treatment, Psoriasis

Fiorillo, Loretta; Becker, Emily; de Lucas, Raul; Belloni-Fortina, Anna; Armesto, Susana; Elewski, Boni; Maes, Peter; Oberoi, Ranjeet; Paris, Maria; Zhang, Wendy; Zhang, Zuoshun; Arkin, Lisa

doi:10.17632/bdydt4v6w8.2

Supplemental Materials for Fiorillo et al. Efficacy And Safety Of Apremilast In Pediatric Patients With Moderate-To-Severe Plaque Psoriasis: 16-Week Results From SPROUT, A Randomized Controlled Trial

Published: 21 December 2023| Version 2 | DOI: 10.17632/bdydt4v6w8.2

Contributors:

Loretta Fiorillo, Emily Becker, Raul de Lucas, Anna Belloni-Fortina, Susana Armesto, Boni Elewski, Peter Maes, Ranjeet Oberoi, Maria Paris, Wendy Zhang, Zuoshun Zhang, Lisa Arkin

Description

Mendeley Supplemental Figures for Loretta Fiorillo et al. Efficacy And Safety Of Apremilast In Pediatric Patients With Moderate-To-Severe Plaque Psoriasis: 16-Week Results From SPROUT, A Randomized Controlled Trial

Supplemental Materials for Fiorillo et al. Efficacy And Safety Of Apremilast In Pediatric Patients With Moderate-To-Severe Plaque Psoriasis: 16-Week Results From SPROUT, A Randomized Controlled Trial

Description

Files

Categories

Licence